Scot Garg
Overview
Explore the profile of Scot Garg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
246
Citations
2972
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
He X, Tsung-Ying T, Revaiah P, Wykrzykowska J, Rosseel L, Sharif F, et al.
Int J Cardiovasc Imaging
. 2024 Oct;
40(12):2469-2479.
PMID: 39395074
Background: Growing evidence shows an association between higher post-PCI quantitative flow ratios (QFR) and improved clinical prognosis, however, no models are available to predict suboptimal QFRs (< 0.91) after angiographically...
12.
Aldujeli A, Tsai T, Haq A, Tatarunas V, Garg S, Hughes D, et al.
Atherosclerosis
. 2024 Sep;
398:118597.
PMID: 39316928
Background And Aims: Coronary microvascular dysfunction (CMD) is common after ST-elevation myocardial infarction (STEMI), leading to adverse clinical outcomes. However, its diagnosis remains difficult, and mechanisms elusive. This study explores...
13.
Tsai T, Elzomor H, Wienemann H, Revaiah P, von Bardeleben R, Tamm A, et al.
Struct Heart
. 2024 Sep;
8(5):100346.
PMID: 39290676
Background: JenaValve's Trilogy transcatheter heart valve (THV) (JenaValve Inc, Irvine, CA) is the only -marked THV system for the treatment of aortic regurgitation (AR) or aortic stenosis (AS). However, its...
14.
Gao C, He X, Ouyang F, Zhang Z, Shen G, Wu M, et al.
Lancet
. 2024 Sep;
404(10457):1040-1050.
PMID: 39236727
Background: The long-term impact of drug-coated balloon (DCB) angioplasty for the treatment of patients with de novo coronary artery lesions remains uncertain. We aimed to assess the non-inferiority of DCB...
15.
Abdelshafy M, Serruys P, Kim W, Ruck A, Wang R, Tao L, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(3):100037.
PMID: 39131960
Background: Aortic regurgitation (AR) following transcatheter aortic valve replacement (TAVR) is a major predictor of short- and long-term survival. Thus far, no independent quantitative comparison of AR among commercially available...
16.
Serruys P, Zhou J, Hara H, Garg S, Onuma Y
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(4):100345.
PMID: 39131929
No abstract available.
17.
Ninomiya K, Serruys P, Garg S, Hara H, Masuda S, Kageyama S, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(4):133.
PMID: 39076220
Background: Personalized prognosis plays a vital role in deciding between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with three-vessel disease (3VD). The aim of this...
18.
Miyashita K, Ninomiya K, Tobe A, Masuda S, Kotoku N, Kageyama S, et al.
Expert Rev Cardiovasc Ther
. 2024 Jul;
22(8):391-407.
PMID: 39049728
Introduction: The higher scaffold thrombosis rates observed with the first-generation bioresorbable scaffolds (BRSs) compared to conventional drug-eluting stents were likely due in part to bioresorbable polymers having insufficient radial strength,...
19.
Kageyama S, Taylor C, Updegrove A, Garg S, Masuda S, Revaiah P, et al.
J Cardiovasc Comput Tomogr
. 2024 Jun;
18(5):478-488.
PMID: 38944640
Background: Coronary artery lumen volume (V) to myocardial mass (M) ratio (V/M) can show the mismatch between epicardial coronary arteries and the underlying myocardium. Methods: The V, M and V/M...
20.
Tobe A, Garg S, Mollmann H, Ruck A, Kim W, Buono A, et al.
Struct Heart
. 2024 May;
8(3):100277.
PMID: 38799801
Inferior outcomes with ACURATE neo, a self-expanding transcatheter heart valve (THV) for the treatment of severe aortic stenosis, were mainly driven by higher rates of moderate/severe paravalvular leak (PVL). To...